LGALS3 and type 2 diabetes mellitus: The authors emphasized that miR-21, in particular, may outperform miR-1 in predicting AHF in asymptomatic T2DM and that a biomarker panel combining miR-21 with NT-proBNP and Gal-3 provides enhanced predictive accuracy.